Search research articles
Contact Us
Filters
Showing results (211-220 of 353) with videos related to
Page
of 36
Sort By:
European Heart Journal
|
April 13, 2006
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial
Padma Kaul, Wei-Ching Chang, A Michael Lincoff, et al.
American Heart Journal
|
April 29, 2006
Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial
Matthews Chacko, A Michael Lincoff, Katherine E Wolski, et al.
Journal of Cardiology
|
December 2, 2017
Efficacy and safety of bivalirudin in coronary artery disease patients with mild to moderate chronic kidney disease: Meta-analysis
Xiaofang Zeng, A Michael Lincoff, Stefanie Schulz-Schüpke, et al.
Circulation. Cardiovascular Quality and Outcomes
|
September 23, 2025
Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries
Amgad Mentias, Neil Keshvani, Milind Y Desai, et al.
American Heart Journal
|
April 17, 2025
Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trial
Thiago Gagliano-Jucá, Karol M Pencina, Yili V Shang, et al.
JAMA Cardiology
|
December 23, 2025
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial
Stephen J Nicholls, Donna H Ryan, John Deanfield, et al.
American Heart Journal
|
September 11, 2013
Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial
A Michael Lincoff, Jean-Claude Tardif, Bruce Neal, et al.
Journal of the American College of Cardiology
|
June 21, 2005
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial
Hitinder S Gurm, Ian J Sarembock, Dean J Kereiakes, et al.
The American Journal of Cardiology
|
December 28, 2014
Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction
Josephine Warren, Roxana Mehran, Jennifer Yu, et al.
Circulation
|
April 30, 2003
Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury
Zhongmin Zhou, Kai Wang, Marc S Penn, et al.
Page
of 36
Search research articles
Search
Showing results (211-220 of 353) with videos related to
Sort By:
Page
of 36
European Heart Journal
|
April 13, 2006
Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial
Padma Kaul, Wei-Ching Chang, A Michael Lincoff, et al.
American Heart Journal
|
April 29, 2006
Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial
Matthews Chacko, A Michael Lincoff, Katherine E Wolski, et al.
Journal of Cardiology
|
December 2, 2017
Efficacy and safety of bivalirudin in coronary artery disease patients with mild to moderate chronic kidney disease: Meta-analysis
Xiaofang Zeng, A Michael Lincoff, Stefanie Schulz-Schüpke, et al.
Circulation. Cardiovascular Quality and Outcomes
|
September 23, 2025
Temporal Trends, Patient Characteristics, and Outcomes of Type 2 Versus Type 1 Myocardial Infarction Among Medicare Beneficiaries
Amgad Mentias, Neil Keshvani, Milind Y Desai, et al.
American Heart Journal
|
April 17, 2025
Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trial
Thiago Gagliano-Jucá, Karol M Pencina, Yili V Shang, et al.
JAMA Cardiology
|
December 23, 2025
Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease: An Exploratory Analysis of the SELECT Randomized Clinical Trial
Stephen J Nicholls, Donna H Ryan, John Deanfield, et al.
American Heart Journal
|
September 11, 2013
Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial
A Michael Lincoff, Jean-Claude Tardif, Bruce Neal, et al.
Journal of the American College of Cardiology
|
June 21, 2005
Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial
Hitinder S Gurm, Ian J Sarembock, Dean J Kereiakes, et al.
The American Journal of Cardiology
|
December 28, 2014
Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction
Josephine Warren, Roxana Mehran, Jennifer Yu, et al.
Circulation
|
April 30, 2003
Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury
Zhongmin Zhou, Kai Wang, Marc S Penn, et al.
Page
of 36